Cargando…

Preclinical Efficacy of Pro- and Anti-Angiogenic Peptide Hydrogels to Treat Age-Related Macular Degeneration

Pro-angiogenic and anti-angiogenic peptide hydrogels were evaluated against the standard of care wet age-related macular degeneration (AMD) therapy, Aflibercept (Eylea(®)). AMD was modeled in rats (laser-induced choroidal neovascularization (CNV) model), where the contralateral eye served as the con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acevedo-Jake, Amanda, Shi, Siyu, Siddiqui, Zain, Sanyal, Sreya, Schur, Rebecca, Kaja, Simon, Yuan, Alex, Kumar, Vivek A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698576/ https://www.ncbi.nlm.nih.gov/pubmed/34940343 http://dx.doi.org/10.3390/bioengineering8120190

Ejemplares similares

Challenges in Translating from Bench to Bed-Side: Pro-Angiogenic Peptides for Ischemia Treatment
por: Petrak, Karel, et al.
Publicado: (2019)

Angiogenic peptide hydrogels for treatment of traumatic brain injury
por: Ma, Xiaotang, et al.
Publicado: (2020)

Self-Assembly of a Dentinogenic Peptide Hydrogel
por: Nguyen, Peter K., et al.
Publicado: (2018)

iPSC-derived cranial neural crest-like cells can replicate dental pulp tissue with the aid of angiogenic hydrogel()
por: Kobayashi, Yoshifumi, et al.
Publicado: (2021)

TCCR/WSX-1 is a novel angiogenic factor in age-related macular degeneration
por: Sung, Ho Jin, et al.
Publicado: (2012)

Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
por: Wang, Jing, et al.
Publicado: (2021)

Dietary Antioxidants in Age-Related Macular Degeneration and Glaucoma
por: Dziedziak, Jacek, et al.
Publicado: (2021)

Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration
por: Xu, Shuting, et al.
Publicado: (2023)

Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review
por: Van Hove, Amy H., et al.
Publicado: (2015)

Angiogenic Potential in Biological Hydrogels
por: Giraudo, Maria Vittoria, et al.
Publicado: (2020)

Pro-angiogenic therapeutics for preeclampsia
por: Eddy, Adrian C., et al.
Publicado: (2018)

VEGFA Isoforms as Pro-Angiogenic Therapeutics for Cerebrovascular Diseases
por: White, Amanda Louise, et al.
Publicado: (2023)

Endophenotypes for Age-Related Macular Degeneration: Extending Our Reach into the Preclinical Stages of Disease
por: Gorin, Michael B., et al.
Publicado: (2014)

A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration
por: Abidi, Muhammad, et al.
Publicado: (2022)

Oxo-M and 4-PPBP Delivery via Multi-Domain Peptide Hydrogel Toward Tendon Regeneration
por: Park, Ga Young, et al.
Publicado: (2022)

Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness
por: Chaudhuri, Madhurima, et al.
Publicado: (2023)

NR4A1 deletion promotes pro-angiogenic polarization of macrophages derived from classical monocytes in a mouse model of neovascular age-related macular degeneration
por: Droho, Steven, et al.
Publicado: (2023)

Evaluation of a Collagen-Chitosan Hydrogel for Potential Use as a Pro-Angiogenic Site for Islet Transplantation
por: McBane, Joanne E., et al.
Publicado: (2013)

Fibroblasts alter the physical properties of dermal ECM-derived hydrogels to create a pro-angiogenic microenvironment
por: Zhang, Meng, et al.
Publicado: (2023)

Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration
por: Ambreen, Fareeha, et al.
Publicado: (2015)

Spatial-Controlled Coating of Pro-Angiogenic Proteins on 3D Porous Hydrogels Guides Endothelial Cell Behavior
por: Le Bao, Chau, et al.
Publicado: (2022)

An injectable hydrogel combining medicine and matrix with anti-inflammatory and pro-angiogenic properties for potential treatment of myocardial infarction
por: Feng, Jiayin, et al.
Publicado: (2023)

Pro-angiogenic photo-crosslinked silk fibroin hydrogel: a potential candidate for repairing alveolar bone defects
por: Wu, Siyuan, et al.
Publicado: (2023)

Role of amyloid β-peptide in the pathogenesis of age-related macular degeneration
por: Wang, Minwei, et al.
Publicado: (2021)

Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration
por: Wu, Tony, et al.
Publicado: (2023)

Antibacterial and Angiogenic Poly(ionic liquid) Hydrogels
por: Sheng, Chengju, et al.
Publicado: (2022)

Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors
por: Marek-Trzonkowska, Natalia, et al.
Publicado: (2015)

Preclinical Evaluation of UDCA-Containing Oral Formulation in Mice for the Treatment of Wet Age-Related Macular Degeneration
por: Maharjan, Pooja, et al.
Publicado: (2019)

Targeting Lipid Metabolism for the Treatment of Age-Related Macular Degeneration: Insights from Preclinical Mouse Models
por: Landowski, Michael, et al.
Publicado: (2022)

Waffle‐inspired hydrogel‐based macrodevice for spatially controlled distribution of encapsulated therapeutic microtissues and pro‐angiogenic endothelial cells
por: Pham, Chi H. L., et al.
Publicado: (2023)

Peptide:glycosaminoglycan hybrid hydrogels as an injectable intervention for spinal disc degeneration
por: Miles, D. E., et al.
Publicado: (2016)

Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse model
por: Choi, Wonmin, et al.
Publicado: (2023)

Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration (Adv. Sci. 31/2023)
por: Xu, Shuting, et al.
Publicado: (2023)

Macrophages and Macular Degeneration
por: Jager, Martine J.
Publicado: (2014)

Brolucizumab for macular degeneration
Publicado: (2020)

Control of the Immune Response by Pro-Angiogenic Factors
por: Voron, Thibault, et al.
Publicado: (2014)

Leptin’s Pro-Angiogenic Signature in Breast Cancer
por: Gonzalez-Perez, Ruben Rene, et al.
Publicado: (2013)

Peptide redesign for inhibition of the complement system: Targeting age-related macular degeneration
por: Mohan, Rohith R., et al.
Publicado: (2016)

Role of Adiponectin Peptide I (APNp1) in Age-Related Macular Degeneration
por: Logan, Connor, et al.
Publicado: (2022)

Evaluation of a connexin-based peptide for the treatment of age-related macular degeneration
por: Obert, Elisabeth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vkvsrp54b7m7cpddvep2g3c1qf